-+ 0.00%
-+ 0.00%
-+ 0.00%

The innovative drug concept continued to be strong in early trading. Baihua Pharmaceutical had 3 consecutive sales, while Rongchang Biotech, Smart Pharmaceuticals, Wanbang Pharmaceuticals, BeiGene Shenzhou, Xinjiangjiang, and Sanyuan Gene had higher gains.

Zhitongcaijing·08/06/2026 01:41:05
Listen to the news
The innovative drug concept continued to be strong in early trading. Baihua Pharmaceutical had 3 consecutive sales, while Rongchang Biotech, Smart Pharmaceuticals, Wanbang Pharmaceuticals, BeiGene Shenzhou, Xinjiangjiang, and Sanyuan Gene had higher gains.